Latest Breaking News On - Metabolic dysfunction associated steatohepatitis - Page 1 : comparemela.com

Genflow Biosciences PLC Announces Receipt of Grant Funding

Genflow Biosciences PLC Announces Receipt of Grant Funding
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomWaals gewestDominic bergerGenflow biosciencesJon critchleyKeith swannJonathan patersonBob robertsEric leireCapital plus partners ltdGenflow biosciences plcCompany on linkedinNews networkIt forms part of united kingdomBiosciences plc

NeuroBo Pharmaceuticals DA-1241 in Combination with Semaglutide Improves Liver Fibrosis and Demonstrates Additive Hepatoprotective Effects in Pre-Clinical MASH Models Compared to Either Treatment, Alone

NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced that pre-clinical data suggests that DA-1241, a novel G-Protein-Coupled Receptor 119 (GPR119) agonist,.

United kingdomMonika lewinskaSujin leeHenrikb hansenMarshallh woodworthAhyoung kimMichael feighHoon jungMi kyung kimYuna chaeMichael millerNeurobo pharmaceuticalsDonga st research centerMembers of the donga st research centerContract research organizationExchange commission

89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at EASL International Liver Congress

89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at EASL International Liver Congress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoUniversity of california san diegoHank mansbachAnnie changArunj sanyalSheryl seapyRohit loombaLifesci advisorsDivision of gastroenterologyInternational liver congressVirginia commonwealth universityExchange commissionDrug administrationWeek dataPegozafermin trial

How a liver-on-a-chip model of fatty liver disease could assist in preventing a global healthcare crisis

This article explores how a liver-on-a-chip model of fatty liver disease could help in preventing a globalhealthcare crisis.

United statesUnited kingdomMichele vaccaAimee molineuxUniversity of cambridgeClinical researchSponsored contentAssociated steatotic liver diseaseNon alcoholic fatty liver diseaseMetabolic dysfunction associated steatohepatitisNon alcoholic steatohepatitisClinical research associateLiver microphysiological systemContent policyNews medical net

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 7 5%

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 7 5%
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesNassim usmanGyre therapeutics incGyre therapeuticsGet free reportDirector nassim usmanMetabolic dysfunction associated steatohepatitisIts hydronidoneGyre therapeutics daily